Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New sedative aims to make endoscopy safer and smoother

NCT ID NCT06732427

Symptom relief Sponsor: Affiliated Hospital of Nantong University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 18, 2026 · Updated 2 times

Summary

This study compares a new sedative, fospropofol disodium, to the standard drug propofol for people undergoing painless endoscopy. Researchers want to see if the new drug provides steady sedation with fewer side effects like low oxygen or heart problems. About 426 adults aged 50-65 will take part across multiple hospitals.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
fospropofol disodium
What this could lead to
If it works, this could offer a safer sedation option for painless endoscopy with fewer breathing problems and faster recovery.
What could go wrong
This is an early-phase trial with only 426 participants, so results may not apply to everyone. The drug may not prove safer or more effective than propofol.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

426 people

The number who actually took part.

Started

Aug 2025

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age 50-65 years, weight 40-65kg, male or female; 2. Patients undergoing painless gastrointestinal endoscopy or painless colonoscopy; 3. American Society of Anesthesia (ASA) grades I-II; 4. Patients and their families can understand and fill in various rating scales, and voluntarily sign the informed consent form; - Exclusion Criteria: 1. Patients with simple and painless gastroscopy 2. Allergy to this study drug and any ingredients; 3. Patients with pathological obesity / obstructive sleep apnea, patients with difficult respiratory tract management; 4. Acute upper respiratory tract infection and asthma attacks; 5. Liver and kidney insufficiency, abnormal heart function; 6. History of mental disorders, long-term use of analgesics; history of drug addiction and drug use; 7. Do not voluntarily cooperate with the patient or be unsuitable by the investigator to participate in the trial.-

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Efficacy and safety are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Efficacy and safety

Contacts and locations

Locations

  • Affiliated Hospital of Nantong University

    Nantong, Jiangsu, 226001, China

  • Hai 'an People's Hospital

    Hai’an, Jiangsu, 226600, China

  • Qidong People's Hospital

    Qidong, Jiangsu, 226200, China

  • Rudong County Hospital of Traditional Chinese Medicine

    Rudong, Jiangsu, 226400, China

  • Rugao People's Hospital

    Rugao, Jiangsu, 226500, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.